Why Selling an ILIT-Owned Policy Requires Extra Fiduciary Discipline
An Irrevocable Life Insurance Trust (ILIT) is designed to own life insurance outside an insured’s estate and administer proceeds for beneficiaries under the trust terms. When a trustee considers selling an ILIT-owned policy (for example, through a life settlement), the decision isn’t just financial—it’s a fiduciary act that must be defensible, well-documented, and consistent with the trust’s purpose.
Because an ILIT often exists specifically to provide a death benefit, selling the policy can be a major change in strategy. Trustees should approach the decision with a structured process that shows prudence, loyalty, and fairness to all beneficiaries.
The Trustee’s Core Fiduciary Duties in an ILIT Policy Sale
Duty of Loyalty
The trustee must act in the best interests of the beneficiaries, not in the trustee’s personal interest or the interest of the insured, a business partner, or any other party. Conflicts of interest are the quickest way to create liability risk—especially if the trustee is also a beneficiary or has a relationship with a buyer, broker, or advisor.
Duty of Prudence
Trustees are generally expected to use reasonable care, skill, and caution—often under a “prudent investor” standard—when making significant asset decisions. In an ILIT sale, prudence commonly means:
- Confirming the trustee has authority under the trust document to sell the policy
- Understanding the policy’s economics (premium burden, sustainability, loans, riders)
- Comparing realistic alternatives (keep vs reduce vs exchange vs surrender vs sell)
- Seeking competitive market pricing rather than accepting the first offer
Duty to Follow the Trust Terms
The trust instrument controls. Trustees must verify the trust’s powers (including any restrictions on selling or assigning a policy), distribution standards, and any instructions about maintaining insurance. If the trust’s purpose is explicitly tied to providing a death benefit for specific beneficiaries, the trustee should be ready to explain how a sale still fulfills the trust’s objectives (or why circumstances changed enough to justify a different course).
Duty of Impartiality
Many trusts have multiple beneficiaries with different interests (income vs remainder beneficiaries, different family branches, or unequal distribution formulas). Selling a policy can shift value between groups. A trustee generally must consider all beneficiaries fairly and document how the decision balances competing interests.
Duty to Inform and Report
Trustees typically must keep beneficiaries reasonably informed and provide accountings as required by the trust and applicable law. A policy sale often triggers heightened expectations for disclosure—what the policy was worth, how offers were obtained, what fees were paid, and how proceeds will be held or distributed.
Practical rule: If you can’t explain the sale decision in a clear memo backed by documents, the process is probably not fiduciary-grade yet.
A well-documented process protects beneficiaries and the trustee.
ILIT-Specific Risks Trustees Should Evaluate Before Selling
Does the Trust Still Need the Death Benefit?
ILITs are often created to provide estate liquidity, support dependents, or equalize inheritances. If those needs still exist, selling may conflict with the trust’s central purpose. If circumstances changed—estate tax exposure dropped, beneficiaries are financially independent, premiums became unsustainable, or the policy underperformed—those facts should be documented carefully.
Authority, Consents, and Court Involvement
Depending on the trust terms and state law, trustees may consider beneficiary consents, non-judicial settlement agreements, or court approval—especially when the sale is controversial, beneficiaries disagree, or the trustee has a potential conflict.
Transfer, Tax, and Structuring Issues
Policy transfers for value can have tax consequences in certain situations. Trustees should ensure qualified tax guidance is involved to evaluate potential income tax impacts, basis considerations, and how proceeds should be managed within the trust after closing.
Privacy and Medical Records Handling
Selling a policy typically requires sharing medical and personal information to obtain offers. Trustees should handle authorizations and disclosures carefully, limit sharing to what is necessary, and maintain secure records. Poor privacy practices can create legal and reputational exposure.
A Practical “Defensible Process” for Trustees
Step 1: Review the Trust Instrument and Trustee Powers
Confirm the trustee’s authority to sell or assign the policy, any limitations, and the trust’s purpose. Also confirm who has power to remove/replace the trustee and whether any special notice requirements apply.
Step 2: Establish the Baseline Options
- Keep: continue paying premiums and maintain the death benefit
- Modify: reduce face amount, adjust riders, or change premium strategy (where allowed)
- Exchange: evaluate whether a repositioning strategy is appropriate (when relevant)
- Surrender: evaluate cash surrender value and tax impact
- Sell: pursue a settlement and compare net proceeds after fees and taxes
Step 3: Obtain Independent Valuation Support
Because a trustee must show they pursued fair value, it’s common to gather evidence such as policy appraisals, multiple bids, and clear gross-to-net calculations. The more complex the case (loans, UL mechanics, high premiums), the more important this step becomes.
Step 4: Run a Competitive and Transparent Bid Process
Competitive bidding helps demonstrate prudence. Trustees should ensure offers are compared on consistent assumptions (premium schedules, required funding, conditions, and closing timelines) and that fees and compensation are fully understood.
Step 5: Document the Decision and Communicate Appropriately
Prepare a trustee memo or file note summarizing:
- Why the sale is being considered
- What alternatives were evaluated and why they were rejected
- How pricing was obtained and why the selected offer was chosen
- Fees paid and any conflicts disclosed
- How proceeds will be held, invested, or distributed under the trust terms
Common Pitfalls That Create Trustee Liability Risk
- Proceeding without confirming authority in the trust document
- Accepting a single offer without testing the market
- Failing to disclose or manage conflicts of interest
- Not comparing surrender value and other realistic alternatives
- Weak recordkeeping and unclear beneficiary communication
- Overlooking tax/structural issues that change net outcomes
The Takeaway: A Trustee’s Best Protection Is a Clean, Competitive, Documented Process
Selling life insurance owned by an ILIT can be appropriate when the policy no longer serves the trust’s objectives, premiums are unsustainable, or beneficiaries are better served by liquidity today. But because trustees are fiduciaries, the sale must be supported by authority, prudence, fair dealing, and good documentation. A structured process—trust review, alternatives analysis, competitive bidding, and clear reporting—helps protect beneficiaries and reduces trustee liability exposure.
FAQ
Can an ILIT trustee legally sell a life insurance policy owned by the trust?
Often yes, but it depends on the trust’s terms and applicable state law. The trustee should confirm the trust grants authority to sell or assign policies and follow any required notice, consent, or approval steps.
What is the trustee’s biggest fiduciary risk when selling an ILIT policy?
The biggest risks are conflicts of interest and failure to act prudently—such as not seeking competitive offers, not evaluating alternatives, or making a decision that can’t be justified as serving beneficiaries’ interests under the trust terms.
Do trustees need beneficiary consent to sell the policy?
Not always, but consent can be useful in reducing dispute risk—especially when beneficiaries disagree or when the sale changes the trust’s expected outcome. Requirements vary by trust language and state law.
How does a trustee show they obtained fair market value?
Common methods include obtaining multiple bids, using an independent policy appraisal, documenting gross-to-net proceeds, and showing that offers were evaluated on consistent assumptions and conditions.
Should a trustee compare a life settlement to cash surrender value?
Yes. Trustees commonly compare keep vs surrender vs sell because surrender value may be the baseline alternative if the policy is no longer needed, and net outcomes can differ materially depending on loans, taxes, and premium burden.
What if the trustee is also a beneficiary?
That can create a conflict, especially if the sale benefits one beneficiary group more than another. Trustees in this situation often seek independent advice, enhanced documentation, and sometimes beneficiary consents or court involvement depending on the facts.
Does selling an ILIT-owned policy automatically trigger taxes?
Not automatically, but tax outcomes can vary based on policy basis, proceeds, and transaction structure. Trustees should obtain qualified tax guidance to understand potential income tax impacts and how proceeds should be handled within the trust.
Do trustees have special duties around medical privacy in a policy sale?
Yes. Selling a policy often requires sharing medical records to obtain offers. Trustees should ensure proper authorizations are used, limit disclosures to what is necessary, and keep information secure to reduce privacy and liability risks.
Should a trustee seek court approval before selling?
Sometimes. Court approval may be considered when beneficiaries dispute the sale, the trust terms are unclear, the trustee has a conflict, or the transaction is unusually large or complex. The right approach depends on the trust and state law.
What should be included in the trustee’s documentation file?
Typically: trust authority review notes, policy documents and in-force illustrations, surrender values, appraisal or bid summaries, fee disclosures, conflict disclosures, decision memo, and records of beneficiary communications and accountings.